z-logo
open-access-imgOpen Access
Extended-Spectrum Beta-Lactamases
Author(s) -
Kevin R. Forward
Publication year - 2006
Publication title -
canadian journal of infectious diseases and medical microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.634
H-Index - 38
eISSN - 1918-1493
pISSN - 1712-9532
DOI - 10.1155/2006/726808
Subject(s) - cephalosporin , antimicrobial , microbiology and biotechnology , bacteria , broad spectrum , biology , medicine , computational biology , antibiotics , chemistry , combinatorial chemistry , genetics
The definition of extended-spectrum beta-lactamases (ESBLs) hasexpanded rapidly, in terms of both the number and the variety ofenzymes. Bacteria bearing plasmidic ESBLs are spreading widelythroughout the world. In Canada, the problem has grown less rapidlythan in other parts of the world; however, ESBLs still present a significantimpediment to the treatment of serious infections with extendedspectrumcephalosporins and penicillins. Although SHV-derivedenzymes were the primary concern in the late 1980s and early 1990s,these enzymes have been rapidly overtaken by the CTX-M family ofESBLs. There is no reason to believe that the problem of ESBLs willnot expand rapidly in the face of intense antimicrobial pressure andlapses in infection control practices. Control should focus on earlydetection, accurate characterization, effective treatment and measuresto prevent further spread

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom